Morgan Stanley’s Achillion Pharmaceuticals ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-473,973
Closed -$2.86M 6913
2019
Q4
$2.86M Buy
473,973
+111,253
+31% +$644K ﹤0.01% 3741
2019
Q3
$1.31M Sell
362,720
-468,677
-56% -$1.81M ﹤0.01% 4126
2019
Q2
$2.23M Buy
831,397
+760,761
+1,077% +$2.25M ﹤0.01% 3688
2019
Q1
$210K Sell
70,636
-224,772
-76% -$552K ﹤0.01% 5040
2018
Q4
$469K Buy
295,408
+53,450
+22% +$151K ﹤0.01% 4828
2018
Q3
$890K Sell
241,958
-81,131
-25% -$242K ﹤0.01% 4629
2018
Q2
$914K Sell
323,089
-1,433
-0.4% -$4.88K ﹤0.01% 4684
2018
Q1
$1.21M Sell
324,522
-4,486,067
-93% -$14.7M ﹤0.01% 4414
2017
Q4
$13.9M Buy
4,810,589
+4,294,088
+831% +$15.6M ﹤0.01% 2059
2017
Q3
$2.32M Buy
516,501
+216,525
+72% +$961K ﹤0.01% 3732
2017
Q2
$1.38M Sell
299,976
-1,614,927
-84% -$6.49M ﹤0.01% 4126
2017
Q1
$8.06M Sell
1,914,903
-475,929
-20% -$1.98M ﹤0.01% 2414
2016
Q4
$9.87M Buy
2,390,832
+2,027,775
+559% +$10.8M ﹤0.01% 2271
2016
Q3
$2.94M Buy
363,057
+246,308
+211% +$2.09M ﹤0.01% 3173
2016
Q2
$911K Buy
116,749
+77,980
+201% +$669K ﹤0.01% 4045
2016
Q1
$300K Sell
38,769
-194,452
-83% -$1.42M ﹤0.01% 4742
2015
Q4
$2.52M Buy
233,221
+205,405
+738% +$1.87M ﹤0.01% 3293
2015
Q3
$192K Sell
27,816
-95
-0.3% -$774 ﹤0.01% 5112
2015
Q2
$247K Sell
27,911
-896,148
-97% -$8.48M ﹤0.01% 5142
2015
Q1
$9.11M Buy
924,059
+890,381
+2,644% +$11.1M ﹤0.01% 2143
2014
Q4
$412K Sell
33,678
-168,119
-83% -$2.05M ﹤0.01% 4810
2014
Q3
$2.01M Sell
201,797
-773,848
-79% -$7.18M ﹤0.01% 3428
2014
Q2
$7.38M Buy
975,645
+365,844
+60% +$1.46M ﹤0.01% 2299
2014
Q1
$2.01M Sell
609,801
-159,709
-21% -$559K ﹤0.01% 3416
2013
Q4
$2.56M Buy
769,510
+605,323
+369% +$1.76M ﹤0.01% 3195
2013
Q3
$495K Sell
164,187
-87,490
-35% -$600K ﹤0.01% 4341
2013
Q2
$2.06M Buy
+251,677
New +$1.92M ﹤0.01% 3129